We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synthesis Success Drives Development of Anti-cancer Agent

News   Jun 18, 2019 | Original story from Harvard University

 
Chemists’ Success in Synthesis Drives Development of Anti-cancer Agent
 
 
 

RELATED ARTICLES

Immune Cells Put Into Gear by Molecular "Clutch"

News

Proteins that drive activation of our immune response, by acting as a ‘clutch’ to move clusters of proteins within cells, have been identified. This could open opportunities to design immune cells to combat specific problems.

READ MORE

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

Toxic Chemical in Marine Ecosystems Turns Out to Be Beneficial

News

A reactive oxygen species produced by one type of phytoplankton, the diatom Thalassiosira oceanica, associated with cellular damage actually aids photosynthesis, according to a recent study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE